Penumbra, Inc. (PEN) Guidance & Earnings Results
On 2026-02-25 Penumbra, Inc. issued guidance: "No guidance provided due to pending…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
PENPenumbra, Inc.Follow PEN — free
—
Price chart with a free account
- Market cap
- 12.8B
- P/E TTM
- 79.7
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 25 Feb 26 | — | No guidance provided due to pending acquisition. |
| 15 Jan 26 | Raised | Q4 2025 revenue growth ~21.4-22.0%; FY2025 revenue ~$1.4B |
| 5 Nov 25 | Raised | Full-year 2025 revenue guidance raised to $1.375B-$1.380B (15-16% growth) · full year |
| 29 Jul 25 | Raised | FY25 revenue raised to $1.355-1.370B from $1.195B (prior year actual); U.S. Thrombectomy growth maintained at 20-21%; gross margin and operating margin guidance maintained. · full year |
Penumbra, Inc. — questions
- What guidance did Penumbra, Inc. give?
- On 2026-02-25: "No guidance provided due to pending acquisition."
- When does Penumbra, Inc. report earnings?
- Penumbra, Inc.'s next earnings report is expected on 2026-11-04.
Every figure on this page comes from Penumbra, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.